A University of Pennsylvania psychiatry professor is alleging that several colleagues - including his department chair - allowed their names to be added to a medical journal manuscript but gave control of the contents to GlaxoSmithKline. Read article at pharmalot.com
Monday, July 25, 2011
More medical ghostwriting
Posted by Willow at 3:12 pm
Labels: GlaxoSmithKline, medical ghostwriting, psychiatrists
Subscribe to: